GSK plc Transactions on July 9, 2026
This report details several transactions involving GSK plc ordinary shares on July 9, 2026. Several individuals, including Lynn Baxter (President, Europe), Julie Brown (Chief Financial Officer), James Ford (SVP and Group General Counsel), David Redfern (President, Corporate Development), Regis Simard (President, Global Supply Chain), Philip Thomson (President, Global Affairs), Deborah Waterhouse (CEO, ViiV Healthcare), and Victoria Whyte (SVP & Company Secretary), acquired ordinary shares. These acquisitions were part of the Company's Share Reward Plan or through the re-investment of dividends paid on July 9, 2026. The transactions occurred on the London Stock Exchange (XLON) at a price of Β£19.6290 or Β£19.6297 per share. The total number of shares acquired varied per individual, with some transactions involving partnership shares and matching shares.